P/E at 65.67 vs Industry's 66.57: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Close to Industry Norms

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 65.67, marginally below the hospital industry average of 66.57. This near parity suggests that the market is pricing the stock in line with sector expectations, reflecting neither a significant premium nor a discount. Such a valuation alignment is notable given the company’s large-cap status with a market capitalisation of ₹1,28,173.96 crores, indicating investor confidence in its earnings stability relative to peers.

However, the slight discount to the sector P/E could be interpreted as a cautious stance by the market, possibly due to recent volatility or sector-specific headwinds. Apollo Hospitals trades close to its 52-week high, just 0.84% shy of ₹9,008.9, which may also temper expectations of further immediate upside. Apollo Hospitals Enterprise Ltd.’s valuation thus reflects a balance between growth prospects and prevailing market caution — previously rated Hold, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Medium-Term Gains Amid Short-Term Stability

Examining the stock’s returns reveals a compelling divergence between medium and short-term performance. Over the past year, Apollo Hospitals has delivered a robust 21.22% gain, comfortably outperforming the Sensex’s 6.26% decline. This outperformance extends to longer horizons, with three-year returns at 72.54%, five-year returns at 135.82%, and an impressive ten-year return of 547.91%, all substantially ahead of the Sensex’s respective 17.25%, 45.76%, and 178.27% gains.

In the shorter term, the stock’s momentum remains positive but more subdued. The one-month return of 6.25% and three-month return of 17.98% both surpass the Sensex’s modest 0.85% and negative 0.68% returns respectively. Year-to-date, the stock has gained 26.58%, contrasting with the Sensex’s 9.11% loss. Even the one-week performance of 0.81% slightly trails the Sensex’s 0.94%, while the one-day return of -0.22% underperforms the Sensex’s 0.36% gain.

This pattern suggests that while Apollo Hospitals Enterprise Ltd. has maintained strong medium-term momentum, recent trading days have seen some profit-taking or consolidation — is this a temporary pause or a sign of shifting investor sentiment? The stock has recorded a three-day consecutive gain, rising 1.78%, indicating resilience despite minor intraday setbacks.

Moving Average Configuration: Bullish Across All Key Indicators

The technical picture for Apollo Hospitals Enterprise Ltd. is notably positive. The stock is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning suggests a sustained upward trend and a strong technical foundation.

Being above the 200-day moving average is particularly significant, as it often signals a long-term bullish trend. The fact that the stock is also above the shorter-term averages indicates recent momentum has been supportive, reinforcing the medium-term performance gains observed. This configuration contrasts with many stocks that may be caught in short-term rallies within longer downtrends — is this a confirmation of trend continuation or a prelude to consolidation?

Sector Performance Context: Hospital Industry Shows Mixed Results

The hospital sector has experienced a mixed performance landscape recently, with a combination of positive, flat, and negative results across constituent stocks. Apollo Hospitals Enterprise Ltd. stands out as a large-cap leader with consistent gains, as reflected in its valuation and price momentum.

While some peers have struggled with margin pressures and regulatory challenges, Apollo Hospitals has maintained steady growth, supported by its diversified healthcare services and strong brand presence. This relative strength within a mixed sector environment underscores the stock’s appeal — does this resilience justify a reassessment of its investment case?

Rating Context: Previously Hold, Now Reassessed

Apollo Hospitals Enterprise Ltd. was previously rated Hold by MarketsMOJO, with a Mojo Score of 75.0. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technicals. The data-driven approach behind this reassessment considers the stock’s valuation close to industry norms, strong medium- and long-term performance, and bullish moving average configuration.

This comprehensive evaluation highlights the stock’s sustained outperformance relative to the Sensex and its sector peers. Yet, the recent short-term underperformance and slight valuation discount suggest a nuanced outlook — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Balanced Yet Positive Picture

The valuation of Apollo Hospitals Enterprise Ltd. closely mirrors its hospital industry peers, indicating market confidence without excessive premium. Its strong one-year and longer-term returns, combined with a technical setup above all key moving averages, point to a robust performance trajectory. The stock’s recent short-term fluctuations and sector-wide mixed results introduce some caution, but the overall data suggests a balanced, positive stance.

Investors analysing Apollo Hospitals should weigh these factors carefully — what is the current rating and how does it align with your portfolio strategy?

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today